% | $
Quotes you view appear here for quick access.

Celldex Therapeutics, Inc. Message Board

  • discoallnightlong discoallnightlong Sep 6, 2013 2:37 PM Flag

    Amazing Drop On Very Small Volume


    A bullish sign.

    This topic is deleted.
    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • I don't recognize your comment as valid whatsoever.
      Firstly, please recognize CLDX is a long way away from bringing anything to market. Secondly, The current Huff and Puff show to keep this share price so inflated is somewhat comical to say the least and regardless of Syria and/or Tapering and/ or any other conundrum that a few people on this board can derive from holding 1000 shares of this POS Co. is again, somewhat comical.

      It shouldn't be much longer before the principals of this Co. exercise their stock into the market place and this current share price replicates single digit pricing sooner than later.

      Stay Long this weekend please and have a great one.


      • 3 Replies to josephblough939
      • temporal Sep 6, 2013 3:57 PM Flag

        Cracks me up when people new to CLDX and new to this board pop up with old, hashed over bashing ideas that have been addressed and discarded many times over as if they were the greatest idea since sliced bread :D

        Sentiment: Strong Buy

      • And I you divine little smugish a--- o-le do NOt recognize your NEWLY BORN name today on this board. A long way from bringing anything to market, please explain, you idiot who does not know how to read core fundamentals or peer reviewed journals detailing the breadth and depth of what they actually have and fully own, nor the black and white of the data to date on any of late stage trials, and while you're at it, idiot, go to PCYC and make the same argument there.

      • You are such an ignorant fool about CLDX. Management will exercise their options when the share price exceeds $150. They know they've got a gold mine. As for being a long way away from market, the outstanding data in novel, revolutionary cancer treatments is the writing on the wall that FDA approval and commercialization are nearly in the bag. The share price is reflecting that growing realization among institutional investors, as are the frequently increasing price targets by institutions. You think that's "huff and puff" and "comical"? You'll be on the sidelines watching other people make boatloads of money.

        Sentiment: Strong Buy

27.80+0.66(+2.43%)May 22 4:00 PMEDT